ARS Pharmaceuticals, Inc. SPRY

US Biotechnology

$3.63 ▲ +15.24% (+$0.48)

⬆️ Above Yest. High 🔥 High Short Interest

Open $3.15

Prev Close $3.15

Day Range $3.07 – $3.64

52W Range $2.44 – $13.15

Market Cap $316.66M

Beta 0.98

EPS (TTM) $-2.17

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2020-12-04
Shares Out.	99,450,000
Website	ars-pharma.com/ ↗
Phone	18009279800
Employees	206
Revenue	$37.7M
Gross Profit	$27.6M
Net Income	-$35.6M
Free Cash Flow	-$183.1M
Total Assets	$251.5M
Total Liabilities	$263.4M
Equity	-$12.0M

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

ARS Pharmaceuticals, Inc. is a publicly traded company under the ticker symbol SPRY on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.